Clinical Trial Detail

NCT ID NCT02882321
Title Study of IACS-010759 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

IACS-010759

Age Groups: adult senior

No variant requirements are available.